Peter W. Rodino III Buys 30,865 Shares of AIM ImmunoTech Inc. (NYSE:AIM) Stock

AIM ImmunoTech Inc. (NYSE:AIM) COO Peter W. Rodino III purchased 30,865 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was purchased at an average cost of $0.41 per share, for a total transaction of $12,654.65. Following the acquisition, the chief operating officer now owns 212,583 shares of the company’s stock, valued at approximately $87,159.03. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

AIM ImmunoTech Price Performance

AIM ImmunoTech stock opened at $0.43 on Thursday. The stock has a market cap of $21.57 million, a price-to-earnings ratio of -0.71 and a beta of -0.11. The business has a 50-day simple moving average of $0.43 and a 200 day simple moving average of $0.44. AIM ImmunoTech Inc. has a 52 week low of $0.32 and a 52 week high of $0.75.

AIM ImmunoTech (NYSE:AIM) last issued its quarterly earnings data on Friday, March 29th. The company reported ($0.26) EPS for the quarter. AIM ImmunoTech had a negative return on equity of 121.69% and a negative net margin of 14,337.62%. The business had revenue of $0.07 million for the quarter.

About AIM ImmunoTech

AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS).